Drugs Made In America Acquisition (DMIIR) Liabilities and Shareholders Equity (2024 - 2026)
Drugs Made In America Acquisition (DMIIR) posted quarterly Liabilities and Shareholders Equity of $505.0 million for Q4 2025, up 365643.31% year-over-year from N/an in Q4 2024, and up 0.79% quarter-over-quarter from $501.0 million in Q3 2025.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIR) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has reported Liabilities and Shareholders Equity for 2 consecutive years, with $505.0 million the latest figure, recorded in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | 376.80 Mn |
| 3 | K&F Growth Acquisition | 836.15 Mn | 836.15 Mn | - | 305.41 Mn |
| 4 | Armada Acquisition | 666.23 Mn | 666.18 Mn | - | 241.34 Mn |
| 5 | Pioneer Acquisition I | 652.74 Mn | 652.27 Mn | - | 263.46 Mn |
| 6 | Oxley Bridge Acquisition | 652.11 Mn | 652.11 Mn | - | 261.48 Mn |
| 7 | Titan Acquisition | 651.43 Mn | 941.85 Mn | - | 291.00 Mn |
| 8 | GSR IV Acquisition | 622.22 Mn | 622.22 Mn | - | 238.06 Mn |
| 9 | Launch One Acquisition | 618.70 Mn | 618.70 Mn | - | 250.27 Mn |
| 10 | Drugs Made In America Acquisition | 5.10 Mn | 5.10 Mn | - | 514.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 514.10 Mn |
| Dec 31, 2025 | 504.96 Mn |
| Sep 30, 2025 | 501.01 Mn |
| Dec 31, 2024 | 138,064.00 |